This practice is supported by in vitro studies that have led to the identification of the molecular effects of synthetic and natural SIRT1-activating compounds in various renal cell types, demonstrating protective effects against renal disorders through modulation of SIRT1 downstream target proteins (Figure 1 and Figure 2). Here, SIRT1 is linked to kidney disorder.